Editorial Policy

Last updated: April 2, 2026

GLP-1 Picks is committed to providing honest, accurate, and useful information to help consumers navigate the GLP-1 telehealth market. This page explains our research methodology, ranking process, and editorial standards.

How We Rank Providers

Each provider on our site receives a score out of 10 based on our evaluation across five categories:

  • Cost & Pricing Transparency (25%) — Monthly price, hidden fees, pricing clarity, available discounts and payment plans
  • Clinical Support Quality (25%) — Physician oversight, follow-up frequency, lab work inclusion, dose titration protocols
  • Medication Options (20%) — Brand-name availability, compounded options, oral vs injectable, medication variety
  • User Experience (15%) — Sign-up process, platform usability, shipping speed, customer support responsiveness
  • Insurance & Accessibility (15%) — Insurance acceptance, prior authorization support, geographic availability, financial assistance programs

Our Research Process

  • We review each provider's website, pricing pages, and sign-up flow
  • We reference published clinical trial data for medication efficacy claims (e.g., STEP, SURMOUNT, OASIS trials published in NEJM)
  • We use FDA prescribing information as the source for side effect data
  • We reference CMS and state Medicaid program announcements for insurance coverage information
  • We update pricing and provider details at least monthly

Editorial Independence

Our editorial team operates independently from our business team. Affiliate relationships do not influence our rankings, scores, or editorial recommendations. We rank providers we are not affiliated with when they deserve inclusion. We give low scores to affiliated providers when warranted.

Medical Accuracy Standards

  • We do not make independent claims about drug efficacy — we reference published clinical trial results and FDA-approved labeling
  • When discussing medication benefits, we include relevant risk information (fair balance)
  • We cite our sources and link to primary sources when possible
  • We do not promote off-label drug use
  • We clearly distinguish between FDA-approved medications and compounded alternatives

Corrections Policy

If we publish inaccurate information, we correct it promptly and transparently. If you notice an error, please contact us at hello@glp1picks.com and we will investigate and correct it within 48 hours.

Content Freshness

The GLP-1 market changes rapidly. We display "Last updated" dates on our content and re-verify provider information monthly. Pricing data is checked against source websites at least once per month.